Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

638
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
638
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

4.0K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.0K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

767
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
767
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

767
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
767

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antimicrobial resistance and associated risk factors in urinary tract infections diagnosed in the emergency department: a retrospective observational study.

BMC infectious diseases·2026
Same author

Missed confirmatory HCV RNA testing in anti-HCV-reactive patients and the role of reflex testing in improving completion of the hepatitis C diagnostic care cascade: a laboratory-based retrospective study.

BMC infectious diseases·2026
Same author

Investigation of viscerotropism-associated genes in <i>Leishmania tropica</i> strains causing visceral leishmaniasis.

Frontiers in microbiology·2026
Same author

Safety Assessment of Probiotics and Postbiotics: A Critical Review.

Current pharmaceutical biotechnology·2026
Same author

Efficacy and Safety of Direct-Acting Antivirals in Patients with Hepatitis C Infection: Nationwide Real-life Data from Türkiye.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology·2026
Same author

Psychological and motor outcomes of botulinum toxin in hemifacial spasm and blepharospasm.

International ophthalmology·2026

Related Experiment Video

Updated: Apr 7, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.7K

Is adiponectin a risk factor for transient ischaemic attacks?

Ufuk Sener, Irem Fatma Uludag1, Sukran Kose

  • 1Department of Neurology, S.B. Tepecik Training and Research Hospital, Izmir-Turkey. fatmairem@yahoo.com.

Endokrynologia Polska
|July 3, 2015
PubMed
Summary
This summary is machine-generated.

Adiponectin levels did not differ between transient ischaemic attack patients and healthy individuals. This study suggests adiponectin is not a predictive risk factor for transient ischaemic attack, despite its role in atherosclerosis.

More Related Videos

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
08:27

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

20.3K
Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
05:32

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model

Published on: August 11, 2023

3.3K

Related Experiment Videos

Last Updated: Apr 7, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

15.7K
The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
08:27

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse

Published on: July 25, 2011

20.3K
Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
05:32

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model

Published on: August 11, 2023

3.3K

Area of Science:

  • Cardiovascular Research
  • Metabolic Syndrome
  • Neuroscience

Background:

  • Adiponectin, an adipocytokine, is implicated in atherosclerosis.
  • The role of adiponectin in ischaemic stroke pathogenesis remains debated.
  • Adiponectin has not been previously studied in transient ischaemic attack (TIA).

Purpose of the Study:

  • To investigate the relationship between adiponectin levels and TIA.
  • To examine associations between adiponectin, traditional stroke risk factors, and carotid intima-media thickness in TIA patients.

Main Methods:

  • Study included 40 patients diagnosed with TIA.
  • Assessed traditional ischaemic stroke risk factors.
  • Measured adiponectin levels and carotid intima-media thickness.

Main Results:

  • No significant difference in adiponectin levels was observed between TIA patients and healthy controls.
  • Adiponectin levels showed no association with traditional risk factors for ischaemic stroke.
  • No correlation found between adiponectin and carotid intima-media thickness.

Conclusions:

  • Adiponectin does not appear to be a significant predictive risk factor for TIA.
  • Further research may be needed to fully elucidate adiponectin's role in cerebrovascular events.